Alnylam Pharmaceuticals, Inc.
OXLUMO
Manufacturer:
Alnylam Pharmaceuticals, Inc.
Name:
OXLUMO
HCPCS Code Descriptor:
Injection, lumasiran, 0.5 mg
Category:
J Code
HCPCS:
J0224
NDC(s):
71336-1002-01
Primary Type:
Genetic Disorder
Generic/Specialty Status:
Single-Source
Route of Administration:
Subcutaneous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
OXLUMO is a Genetic Disorder drug manufactured by Alnylam Pharmaceuticals, Inc. and administered via the Subcutaneous route of administration. The J Code: J0224 is aligned to the drug OXLUMO.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/21
HCPCS Effective Date:
7/1/21
HCPCS Short Description:
Inj. lumasiran, 0.5 mg
Billing and Coding Guide:
https://www.alnylamassist.com/sites/default/files/pdfdownloads/OXLUMO-lumasiran-Billing-and-Coding-Guide-for-Physician-Offices.pdf
Patient Assistance:
https://www.alnylamassist.com/
